Full Professor(heuristic)

Glioma Diagnosis and Treatment · Genetics

h-index50
i10-index71
Publications225
Citations15,777

Grants

10 total · 3 active

NIH #5R01NS132780-03

Investigation of ecDNA as a driver of intratumoral heterogeneity and treatment resistance in high-risk medulloblastoma

Active
Amount
$637K
Period
2023-09-01 → 2028-08-31
PIs
1
Est. capacity / PI
~4 students

Awarded at SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE

NIH #5R01NS132780-02

Investigation of ecDNA as a driver of intratumoral heterogeneity and treatment resistance in high-risk medulloblastoma

Active
Amount
$618K
Period
2023-09-01 → 2028-08-31
PIs
1
Est. capacity / PI
~4 students

Awarded at SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE

NIH #1R01NS132780-01

Investigation of ecDNA as a driver of intratumoral heterogeneity and treatment resistance in high-risk medulloblastoma

Active
Amount
$661K
Period
2023-09-01 → 2028-08-31
PIs
1
Est. capacity / PI
~4 students

Awarded at SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE

Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.

All Grants

10 total · 3 active

NIH #5R01NS132780-03

Investigation of ecDNA as a driver of intratumoral heterogeneity and treatment resistance in high-risk medulloblastoma

Active
Amount
$637K
Period
2023-09-01 → 2028-08-31
PIs
1
Est. capacity / PI
~4 students

Awarded at SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE

NIH #5R01NS132780-02

Investigation of ecDNA as a driver of intratumoral heterogeneity and treatment resistance in high-risk medulloblastoma

Active
Amount
$618K
Period
2023-09-01 → 2028-08-31
PIs
1
Est. capacity / PI
~4 students

Awarded at SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE

NIH #1R01NS132780-01

Investigation of ecDNA as a driver of intratumoral heterogeneity and treatment resistance in high-risk medulloblastoma

Active
Amount
$661K
Period
2023-09-01 → 2028-08-31
PIs
1
Est. capacity / PI
~4 students

Awarded at SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE

NIH #7R21NS130137-02

Transcriptional activation of RCOR2 as a novel oncogenic mechanism in supratentorial ependymoma

Amount
$536K
Period
2023-01-07 → 2025-08-31
PIs
1
Est. capacity / PI
~0 students

Awarded at SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE

NIH #7R21NS120075-03

Transcriptional activation of LAMC1 as a resistance mechanism in recurrent PFA Ependymoma

Amount
$196K
Period
2023-01-07 → 2024-05-31
PIs
1
Est. capacity / PI
~0 students

Awarded at SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE

NIH #7R21NS116455-03

Disruption of a DNA loop as a complementary mechanism of H3.3K27M mutations

Amount
$22K
Period
2023-01-07 → 2023-05-31
PIs
1
Est. capacity / PI
~0 students

Awarded at SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE

NIH #5R21NS120075-02

Transcriptional activation of LAMC1 as a resistance mechanism in recurrent PFA Ependymoma

Amount
$39K
Period
2020-12-01 → 2022-11-30
PIs
1
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF CALIFORNIA, SAN DIEGO

NIH #1R21NS120075-01

Transcriptional activation of LAMC1 as a resistance mechanism in recurrent PFA Ependymoma

Amount
$237K
Period
2020-12-01 → 2022-11-30
PIs
1
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF CALIFORNIA, SAN DIEGO

NIH #5R21NS116455-02

Disruption of a DNA loop as a complementary mechanism of H3.3K27M mutations

Amount
$180K
Period
2020-06-01 → 2022-11-30
PIs
1
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF CALIFORNIA, SAN DIEGO

NIH #1R21NS116455-01

Disruption of a DNA loop as a complementary mechanism of H3.3K27M mutations

Amount
$236K
Period
2020-06-01 → 2022-05-31
PIs
1
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF CALIFORNIA, SAN DIEGO

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 20 of 51
Open author page on OpenAlex →